---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-012368"
form_type: "8-K"
ticker: "INBP"
cik: "0001016504"
company_name: "INTEGRATED BIOPHARMA INC"
filed_at: "2026-04-15T23:59:59+00:00"
generated_at: "2026-05-15T05:59:53.034428+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Integrated BioPharma receives 3-month extension of PNC line of credit to July 14, 2026

## Summary
- PNC Bank notified Integrated BioPharma and subsidiary Manhattan Drug on April 14, 2026.
- Line of credit expiration extended from April 15, 2026 to July 14, 2026.
- Extension subject to PNC's sole discretion to designate a later date via written notice.
- No changes to other terms of the promissory note dated April 15, 2025 were disclosed.

## SEC filing metadata
- accession: 0001437749-26-012368
- form_type: 8-K
- ticker: INBP
- cik: 0001016504
- company_name: INTEGRATED BIOPHARMA INC
- filed_at: 2026-04-15T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 9.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1016504/000143774926012368/0001437749-26-012368-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1016504/000143774926012368/inbp20260415_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-012368
- JSON: https://secwatch.observer/filing/0001437749-26-012368.json
- Plain text: https://secwatch.observer/filing/0001437749-26-012368.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.